James A DeCaprio Selected Research

James A DeCaprio Research Topics

Disease

36	Neoplasms (Cancer) 12/2022 - 04/2002
12	Merkel Cell Carcinoma 10/2022 - 10/2017
9	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2002
3	Hyperplasia 01/2022 - 03/2015
3	Carcinogenesis 12/2021 - 01/2017
3	Infections 01/2020 - 09/2006
2	Neuroendocrine Carcinoma 10/2022 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2019
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2014 - 08/2013
2	Virus Diseases (Viral Diseases) 11/2013 - 02/2009
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Trisomy (Trisomies) 01/2019
1	Gracile bone dysplasia 01/2019
1	Type 1 Kenny-Caffey syndrome 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Disease Progression 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Residual Neoplasm 08/2013
1	Pneumonia (Pneumonitis) 02/2009
1	Poliomyelitis (Polio) 09/2006
1	Hypoxia (Hypoxemia) 01/2004
1	Kidney Neoplasms (Kidney Cancer) 01/2004
1	Neoplastic Cell Transformation 04/2002

Drug/Important Bio-Agent (IBA)

15	Tumor Viral Antigens (Large T Antigen)IBA 01/2022 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2002
7	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 09/2006
3	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2017
3	Viral DNAIBA 01/2022 - 12/2012
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2004
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2004
3	Immune Checkpoint InhibitorsIBA 11/2020 - 10/2019
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2022 - 09/2005
2	Phosphotransferases (Kinase)IBA 01/2019 - 07/2014
2	Retinoblastoma ProteinIBA 01/2016 - 03/2004
2	Imatinib Mesylate (Gleevec)FDA Link 07/2014 - 08/2013
1	Polycomb Repressive Complex 2IBA 10/2022
1	Biological ProductsIBA 03/2022
1	AntigensIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Histocompatibility Antigens Class IIBA 01/2022
1	milademetanIBA 01/2022
1	Viral ProteinsIBA 01/2022
1	CarcinogensIBA 01/2021
1	prexasertibIBA 01/2021
1	Circular DNAIBA 01/2020
1	LigandsIBA 01/2020
1	InterferonsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	palbociclibIBA 01/2019
1	PlatinumIBA 01/2018
1	cabozantinibIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Histones (Histone)IBA 01/2017
1	sialosyl-T antigenIBA 03/2015
1	Dyrk KinasesIBA 07/2014
1	Small Interfering RNA (siRNA)IBA 07/2014
1	ChromatinIBA 11/2013
1	Monoclonal AntibodiesIBA 12/2012
1	Cullin 1IBA 09/2010
1	Poliovirus VaccinesIBA 02/2009
1	GTP Phosphohydrolases (GTPases)IBA 06/2007
1	Monomeric GTP-Binding ProteinsIBA 06/2007
1	FluoroquinolonesIBA 01/2007
1	VaccinesIBA 09/2006
1	ATP dependent 26S protease (26S proteasome)IBA 01/2004
1	Complementary DNA (cDNA)IBA 01/2004
1	Von Hippel-Lindau Tumor Suppressor ProteinIBA 01/2004
1	AcidsIBA 01/2004
1	3,4,5- trihydroxy- 2- - methoxy- 8,8- dimethyl- N- (hexahydro- 2- oxo- 6- (cyclohexylcarbonyl)oxy- 2H- azepin- 3- yl)non- 6- enamideIBA 12/2003
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2003
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2018
2	Radiotherapy 03/2021 - 10/2016
2	Immunotherapy 11/2020 - 01/2018
1	Adjuvant Radiotherapy 01/2019
1	Organ Transplantation 01/2019
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2017